172 results on '"DeNicola, Gina"'
Search Results
2. An Activity-Based Sensing Approach to Multiplex Mapping of Labile Copper Pools by Stimulated Raman Scattering
3. MAPK-mediated PHGDH induction is essential for melanoma formation and represents an actionable vulnerability
4. Correction: Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
5. Metabolism in tumor-associated macrophages
6. Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography
7. Retraction Note: NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages
8. ASCT2 is the primary serine transporter in cancer cells
9. eLife assessment: SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
10. A PI3K gene expression signature predicts for recurrence in early‐stage non–small cell lung cancer treated with stereotactic body radiation therapy (SBRT)
11. Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy
12. Figure S3 from Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
13. Figure S5 from Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
14. Figure S4 from Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
15. Figure S2 from Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
16. Figure S2 from Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
17. eLife assessment: DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
18. Figure S1 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
19. Figure S4 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
20. Figure S6 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
21. Figure S7 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
22. Figure S4 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
23. Figure S6 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
24. Figure S3 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
25. Figure S7 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
26. Data from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
27. Figure S5 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
28. Figure S3 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
29. Figure S5 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
30. Figure S1 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
31. Data from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
32. Figure S2 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
33. Figure S2 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
34. NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis
35. Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
36. GAPDH redox redux—rewiring pentose phosphate flux
37. Abstract 2161: Quinolinic acid phosphoribosyl transferase (QPRT) is an essential liability of non-small cell lung cancer
38. Supplementary Data from Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS–MAPK Pathway Inhibition in Pancreatic Cancer
39. Abstract 6029: Multi-omic landscape of squamous cell lung cancer
40. Data from Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS–MAPK Pathway Inhibition in Pancreatic Cancer
41. Supplementary Figure from Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS–MAPK Pathway Inhibition in Pancreatic Cancer
42. Supplementary Figure from Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS–MAPK Pathway Inhibition in Pancreatic Cancer
43. Data from Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS–MAPK Pathway Inhibition in Pancreatic Cancer
44. Supplementary Data from Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS–MAPK Pathway Inhibition in Pancreatic Cancer
45. Supplementary Figure Legends 1-4 from C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D
46. Figure S7 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
47. Figure S6 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
48. Supplementary Figure 4 from C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D
49. Data from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
50. Supplementary Figure 4 from C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.